ESPIRE Technologies GmbH
MedInnovation GmbH is a life science company focused on protein functionality analysis, specifically investigating the transport and binding functions of albumin in blood. Their goal is to improve diagnostics for life-threatening diseases by enabling early detection, thereby increasing patient survival rates. Their technology platform utilizes a blood test for albumin functionality via ESR spectroscopy and aims to develop new lab diagnostic solutions for various diseases including cancer, liver disease, kidney disease, and sepsis. The company is actively involved in research and development, including work on Human Serum Albumin, ESR spectroscopy, and product development involving hardware and software.
ESPIRE Technologies GmbH
MedInnovation GmbH is a life science company focused on protein functionality analysis, specifically investigating the transport and binding functions of albumin in blood. Their goal is to improve diagnostics for life-threatening diseases by enabling early detection, thereby increasing patient survival rates. Their technology platform utilizes a blood test for albumin functionality via ESR spectroscopy and aims to develop new lab diagnostic solutions for various diseases including cancer, liver disease, kidney disease, and sepsis. The company is actively involved in research and development, including work on Human Serum Albumin, ESR spectroscopy, and product development involving hardware and software.
TL;DR
Core product: Albumin-function diagnostics (ESPIRE AFT) using ESR spectroscopy
Key components: ESPIRE ALBUmini (sample-prep dosimeter) and ESPIRE ProSol (test kit with reagents)
Clinical focus: Cancer, liver disease, kidney disease, sepsis
Organization: Presented as a product/project of MedInnovation GmbH (Berlin)
Funding rounds: One Seed round recorded (details obfuscated)
Company Overview
Problem Domain
Laboratory diagnostics for disease detection and therapy monitoring (cancer, liver disease, kidney disease, sepsis).
Founded
1999
Industry
Life sciences / Diagnostic development
Tech Stack
Funding Track Record
Recorded as one Seed round with public details obfuscated